Lipoproteins and apolipoproteins during the progression of chronic renal disease.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Nephron

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000185138PMID 3221949
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.

  2009cited by this paper
• Apolipoproteins C-II and C-III in serum quantified by zone immunoelectrophoresis.

  1987cited by this paper
• Stimulation of lecithin:cholesterol acyltransferase activity by apolipoprotein A-II in the presence of apolipoprotein A-I.

  1986cited by this paper
• Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.

  1985cited by this paper
• Lipoprotein metabolism and the role of apolipoproteins as metabolic programmers.

  1985cited by this paper
• Apolipoprotein and lipid abnormalities in uremic children on hemodialysis.

  1985cited by this paper
• Familial disorders of plasma apolipoproteins

  1985cited by this paper
• Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients.

  1984cited by this paper
• Plasma lipoproteins and lecithin:cholesterol acyltransferase distribution in patients on dialysis.

  1984cited by this paper
• Effect of protein-reduced diet on plasma lipids, apolipoproteins and lipolytic activities in patients with chronic renal failure.

  1984cited by this paper
• De novo development of hypercholesterolemia and elevated high-density lipoprotein cholesterol: apoprotein A-I ratio in patients with chronic renal failure following kidney transplantation.

  1983cited by this paper
• Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitro.

  1983cited by this paper
• Lecithin: cholesterol acyltransferase activity in dialyzed and undialyzed chronic uremic patients.

  1982cited by this paper
• An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III.

  1982cited by this paper
• Increased lipoprotein-remnant formation in chronic renal failure.

  1982cited by this paper
• Plasma lecithin-cholesterol acyltransferase activities in uraemic patients.

  1982cited by this paper
• Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.

  1982cited by this paper
• Plasma lipid alterations in patients with chronic renal disease.

  1982cited by this paper
• Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease.

  1982cited by this paper
• Lipid abnormalities in uremia, dialysis, and transplantation.

  1981cited by this paper
• Lipolytic enzymes and plasma lipoprotein metabolism.

  1980cited by this paper
• Hyperlipoproteinemia in renal insufficiency.

  1980cited by this paper
• Impaired plasma triglyceride clearance as a feature of both uremic and posttransplant triglyceridemia.

  1980cited by this paper
• Postheparin plasma triglyceride lipases in chronic hemodialysis: evidence for a role for hepatic lipase in lipoprotein metabolism.

  1979cited by this paper
• Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis.

  1979cited by this paper
• Apoprotein composition of plasma lipoproteins in uremic patients on hemodialysis.

  1979cited by this paper
• Heparin-released plasma lipases in chronic renal failure and after renal transplantation.

  1979cited by this paper
• Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis.

  1978cited by this paper
• Hepatic and extrahepatic triglyceride lipase activity in uraemic patients on chronic haemodialysis

  1978cited by this paper
• High density lipoproteins--correlation with cardiovascular disease in hemodialysis patients.

  1978cited by this paper
• Adipose tissue lipoprotein lipase in chronic hemodialysis: role in plasma triglyceride metabolism.

  1978cited by this paper
• Accelerated atherosclerosis in chronic-dialysis patients--another look.

  1978cited by this paper
• Dyslipoproteinemia (a remnant lipoprotein disease) in uremic patients on hemodialysis.

  1978cited by this paper
• Selective deficiency of hepatic triglyceride lipase in uremic patients.

  1977cited by this paper
• Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis.

  1977cited by this paper
• Prevalence of serum lipid abnormalities in chronic hemodialysis.

  1977cited by this paper
• Reduction of plasma triglycerides by diet in subjects with chronic renal failure.

  1977cited by this paper
• Bone histology in incipient and advanced renal failure.

  1976cited by this paper
• Accelerated atherosclerosis in prolonged maintenance hemodialysis.

  1974cited by this paper

• Improvement in Kidney Function after Discontinuation of Fenofibrate in Outpatient Nephrology Consultation for Chronic Kidney Disease

  2022cites this paper
• Serum Lipoprotein(a) Level

  2020cites this paper
• Protective Effect of Kaempferol on Biochemical and Histopathological Changes in Mercuric Chloride Induced Nephrotoxicity in Experimental Rats

  2018cites this paper
• Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.

  2017cites this paper
• Serum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama Study

  2017cites this paper
• Cholesterol and Triglyceride Content in Lipoprotein Fractions of Rats Treated with Bovine Serum Albumin

  2016cites this paper
• A Study of Lipid Profile in Chronic Renal Disease with Special Reference to LP ( a )

  2016cites this paper
• DETERMINING THE FEASIBILITY OF THE CARDIAC REHABILITATION PARADIGM AND ITS IMPACT ON EXERCISE SELF-EFFICACY AMONG CHRONIC KIDNEY DISEASE PATIENTS: A PILOT STUDY

  2015cites this paper
• Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease

  2015cites this paper
• Dyslipidemias in the Pediatric Chronic Kidney Disease Patient

  2014cites this paper
• A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease.

  2012influential citation
• Fenofibrate Reversibly Increases Serum Creatinine Level in Chronic Kidney Disease Patients by Reducing Glomerular Filtration Rate

  2011cites this paper
• Prädiktoren des postinterventionellen Outcomes bei Patienten mit kritischer Beinischämie und arteriell-ischämischen Ulcerationen

  2011cites this paper
• Serum Lp(a) concentration in diabetic patients undergoing hemodialysis

  2009cites this paper
• A Study of Lipid Profile in Chronic Renal Failure Patients on Conservative Management, Hemodialysis and After Renal Transplantation

  2008influential citation
• Low‐density lipoprotein oxidizability in children with chronic renal failure

  2008cites this paper
• Prevalence and Possible Causes of Dyslipidemia after Pediatric Solid Organ Transplantation

  2008cites this paper
• Lipoprotein metabolism in chronic renal insufficiency

  2007cites this paper
• Relationship between lipid profiles and kidney function in patients with type 1 diabetes

  2007cites this paper
• Chronic kidney disease: a risk factor for cardiovascular disease.

  2005cites this paper
• Preventing Cardiovascular Outcome in Patients with Renal Impairment

  2005cites this paper
• Uremic Serum Subtraction Inhibits Apolipoprotein A-I Production by a Human Hepatoma Cell Lin &

  2005cites this paper
• Fluvastatin in the Treatment of Dyslipidemia Associated with Chronic Kidney Failure and Renal Transplantation

  2005cites this paper
• The role of the kidney in lipid metabolism

  2005cites this paper
• Manifestations and Risk Factors of Atherosclerosis in Chronic Renal Failure

  2004cites this paper
• Lipid and Lipoprotein Ratios as Risk Factors of Atherosclerosis in Patients with Chronic Renal Insufficiency (CRI)

  2004cites this paper
• Optimization of hypolipidemic and antiplatelet treatment in the diabetic patient with renal disease.

  2004cites this paper
• The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction.

  2004cites this paper
• Estimation of plasma very low density lipoprotein-cholesterol levels in uremia

  2002cites this paper
• Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management

  2002cites this paper
• Accelerated atherosclerosis, dyslipidemia, and oxidative stress in end-stage renal disease

  2002cites this paper
• Fenofibrate Increases Creatininemia by Increasing Metabolic Production of Creatinine

  2002cites this paper
• Nutrition in children with preterminal chronic renal failure. Myth or important therapeutic aid?

  2002cites this paper
• Effect of lipid-lowering dietary recommendations on the nutritional intake and lipid profiles of chronic peritoneal dialysis and hemodialysis patients.

  2001cites this paper
• Evaluation of a Novel Vitamin E Coated Cellulosic Membrane Hollow Fiber Dialyzer

  2001cites this paper
• Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.

  2001cites this paper
• A randomized placebo-controlled double-blind trial of lipid-lowering strategies in patients with renal insufficiency: diet modification with or without fenofibrate.

  2000cites this paper
• [Apolipoprotein C-II and C-III anomalies in normolipemic and hyperlipemic patients with chronic kidney failure].

  2000cites this paper
• Premature cardiovascular disease in chronic renal failure.

  2000cites this paper
• The atherogenic lipoprotein phenotype in renal disease

  1999cites this paper
• Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure.

  1999cites this paper
• Effect of metabolic acidosis on hyperlipidemia in uremia

  1999cites this paper
• Mechanism of oral absorbent AST-120 in lipid abnormalities in experimental uremic rats.

  1999cites this paper
• Lipids increase after solitary pancreas transplantation.

  1999cites this paper
• Effects of two low-flux cellulose acetate dialysers on plasma lipids and lipoproteins--a cross-over trial.

  1998cites this paper
• The interaction of modified low density lipoproteins with glomerular mesangial cells and its potential influence on glomerulosclerosis

  1998cites this paper
• Gastrointestinal complications of renal failure.

  1998cites this paper
• Effects of Treatment of Secondary Hyperparathyroidism on the Lipid Profile in Patients on Hemodialysis

  1998cites this paper
• Hyperlipidemia in patients with chronic renal disease.

  1998cites this paper
• Hyperlipidemia and kidney disease: concepts derived from histopathology and cell biology of the glomerulus.

  1998cites this paper
• Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency.

  1997cites this paper
• Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study.

  1997cites this paper
• Lipids in progression of renal disease.

  1997cites this paper
• Pathogenesis of dyslipoproteinemia in renal insufficiency: the role of lipoprotein lipase and hepatic lipase.

  1997cites this paper
• Le Alterazioni Del Metabolismo Lipidico Nell'uremia: Dalle Fasi Precoci Della Insufficienza Renale Cronica Alla Dialisi

  1997cites this paper
• Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.

  1997cites this paper
• Insufficienza Renale Cronica e Danno Carotideo

  1997cites this paper
• Effects of simvastatin and enalapril on serum lipoprotein concentrations and left ventricular mass in patients on dialysis. The Perfect Study Collaborative Group.

  1997cites this paper
• Dyslipidemia in renal disease.

  1996cites this paper
• [Cardiovascular risk factors in 15 patients in chronic hemodialysis in Temuco city. Descriptive comparison with the general Chilean population].

  1996cites this paper
• Treatment of dyslipidemia in chronic renal failure.

  1996cites this paper
• Cholesterol and triglyceride content in lipoprotein fractions of rats treated with bovine serum albumin.

  1996cites this paper
• Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis.

  1996cites this paper
• Lipoprotein metabolism in renal replacement therapy: a review.

  1996cites this paper
• Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure.

  1996cites this paper
• Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.

  1996cites this paper
• Carotid artery lesions in patients with nondiabetic chronic renal failure.

  1996cites this paper
• [Coronary risk factors in chronic hemodialysis patients].

  1996cites this paper
• Is the determination of LDL cholesterol according to Friedewald accurate in CAPD and HD patients?

  1996cites this paper
• Lipoprotein abnormalities in chronic renal failure and dialysis patients.

  1996cites this paper
• Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure

  1996cites this paper
• Plasma lipid profile and coronary artery disease in Brazilian hemodialysis patients.

  1995cites this paper
• Evidence that reduced lipoprotein lipase activity is not a primary pathogenetic factor for hypertriglyceridemia in renal failure.

  1995cites this paper
• Lipids and atherosclerosis.

  1995cites this paper
• Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.

  1994cites this paper
• Decreased clearance of low-density lipoprotein in patients with chronic renal failure.

  1994cites this paper
• Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency.

  1994cites this paper
• Uremic serum subfraction inhibits apolipoprotein A-I production by a human hepatoma cell line.

  1994cites this paper
• Malnutrition in uremia.

  1994cites this paper
• Serum cholesterol falls spontaneously in nephrotic patients with progressive renal disease.

  1993cites this paper
• Lipoprotein (a) levels in end-stage renal failure and renal transplantation.

  1993cites this paper
• The effects of various antihypertensive agents on cardiovascular risk factors in patients with renal failure.

  1993cites this paper
• Hyperlipoproteinaemia in renal failure: pathogenesis and perspectives for intervention.

  1993cites this paper
• Lipoprotein metabolism and renal failure.

  1993cites this paper
• Must we Treat Uremic Dyslipidemia?

  1993cites this paper
• The relationship between plasma and dialysate lipoproteins and apoproteins in patients treated by continuous ambulatory peritoneal dialysis.

  1993cites this paper
• Lipid abnormalities in chronic uremic patients. Response to treatment with gemfibrozil.

  1993cites this paper
• Dyslipoproteinemia in diabetic renal failure.

  1992cites this paper
• Increased concentrations of Apo B-containing triglyceride-rich lipoprotein particles in patients with chronic renal failure.

  1992cites this paper
• Dietary treatment of uraemia and the relation to lipoprotein metabolism.

  1992cites this paper
• Decreases in apolipoprotein(a) after renal transplantation: implications for lipoprotein(a) metabolism.

  1992cites this paper
• Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure.

  1992cites this paper
• Is Atherogenesis Accelerated in Hemodialysis Patients

  1992influential citation
• [The determination of apolipoproteins. Its possible diagnostic importance].

  1992cites this paper
• Decreased low-density lipoprotein receptor function and mRNA levels in lymphocytes from uremic patients.

  1992cites this paper
• Comparison of lipids, apoproteins and associated enzyme activities between diabetic and nondiabetic end-stage renal disease.

  1992cites this paper
• Lipids and apolipoproteins change during the progression of chronic renal failure.

  1992cites this paper
• Atherogenesis in Chronic Renal Failure

  1992cites this paper
• Ischemic Heart Disease in Chronic Renal Failure: Demography, Epidemiology, and Pathogenesis

  1992cites this paper
• Cardiovascular risk factors in chronic renal failure and hemodialysis populations.

  1992cites this paper